Mindray Medical International Ltd. said Monday it estimates that its adjusted profit in 2010 grew about 10 percent greater than its profit in 2009.
The Shenzhen, China, company also said it estimates its revenue grew about 10 percent. In 2009, Mindray reported a profit of $147.4 million, or $1.30 per share, excluding one-time costs and gains. It expects $703 million in revenue for the year, compared with $634.2 million in 2009.
FactSet says analysts are expecting a profit of $1.38 per share and $701.7 million in revenue on average.
Mindray said it plans to launch seven to 10 new products in 2011, in fields including patient monitoring, defibrillator, anesthesia delivery, and blood analysis. The company said it introduced 10 new products in 2010, giving it about 80 total products.
Shares of Mindray rose $1.43, or 5.3 percent, to $28.48 in morning trading.